bpV(phen) (potassium hydrate) (Synonyms: Bisperoxovanadium(phen), Potassium Bisperoxo(1,10phenanthroline) oxovanadate (V)) |
Catalog No.GC42969 |
bpV(phen) (hydrate de potassium), un agent insulino-mimétique, est un puissant inhibiteur de la protéine tyrosine phosphatase (PTP) et du PTEN avec des IC50 de 38 nM, 343 nM et 920 nM pour le PTEN, PTP-β ; et PTP-1B, respectivement.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 171202-16-7
Sample solution is provided at 25 µL, 10mM.
bpV(phen) is a bisperoxovanadium (bpV) compound which inhibits several different protein tyrosine phosphatases (PTPs), with selectivity for PTEN (IC50 = 38 nM). It also inhibits the vascular endothelial PTP, PTP-β (IC50 = 343 nM), and PTP-1β (IC50 = 920 nM). At 0.1 mM, bpV(phen) inhibits SH2 domain-containing inositol 5'-phosphatase-2. Presumably by inhibiting insulin receptor kinase-associated PTPs, bpV(phen) activates the insulin receptor tyrosine kinase and promotes downstream signaling, including activation of PI3-kinase.
Average Rating: 5
(Based on Reviews and 6 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *